BARK Receives NYSE Notice For Non-Compliance With $1 Minimum Share Price Requirement

BARK, Inc. (BARK) received a NYSE non-compliance notice on July 10, 2025, for failing to maintain a 30-day average closing stock price of $1.00, with its shares recently closing at $0.9225. The company has six months to regain compliance, potentially via a reverse stock split subject to shareholder approval. While the notice does not immediately affect BARK's listing or operations, failure to meet the threshold within the cure period could lead to delisting, signaling significant concern for investors regarding the company's market valuation and future stability.

Analysis

BARK, Inc. has received a formal non-compliance notice from the New York Stock Exchange after its 30-day average closing stock price fell below the $1.00 minimum threshold as of July 9, 2025. This event, underscored by a strongly negative sentiment score of -0.7, formalizes the market's concern over the company's valuation, with its stock recently closing at $0.9225. The company now enters a six-month cure period to regain compliance, a process that requires not only its stock to close above $1.00 on the last day of a month but also to maintain a 30-day average above that level. Management's consideration of a reverse stock split as a potential remedy is a significant governance event to watch, as it addresses the technical listing requirement but does not solve the underlying issues that led to the price decline. While there is no immediate impact on BARK's trading status or operations, the notice serves as a critical warning and places the company under significant pressure to restore investor confidence or face delisting.

Key Decisions for Investors

• Investors should closely monitor BARK's ability to achieve and sustain a stock price above the $1.00 threshold within the six-month cure period, as failure to do so presents a direct delisting risk.
• The potential for a reverse stock split is a key event to watch; while it could resolve the compliance issue, it is often viewed as a negative signal and does not address the fundamental business performance that has depressed the stock's value.
• Given the heightened uncertainty and delisting risk, the stock should be considered highly speculative, warranting a review of position sizing for existing holders and extreme caution for those considering new positions until a clear path to sustained compliance is demonstrated.